vimarsana.com
Home
Live Updates
Kamada Announces its Largest Commercial Agreement; A Strateg
Kamada Announces its Largest Commercial Agreement; A Strateg
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years
Largest Commercial Agreement in Kamada’s History Becomes Effective in January 2024 and Includes $180 Million of Revenues to Kamada Over the First Four Years of the Eight Year TermFinancial Terms...
Related Keywords
Australia ,
Texas ,
United States ,
India ,
Canada ,
Russia ,
Argentina ,
Brazil ,
Rehovot ,
Hamerkaz ,
Israel ,
America ,
Israeli ,
Chaime Orlev ,
Kedrion Biopharma ,
Brian Ritchie ,
Globenewswire Inc ,
Kamada Ltd ,
Lifesci Advisors ,
Israeli Ministry Of Health ,
Us Securities Exchange ,
Nasdaq ,
Exchange Commission ,
European Medicines Agency ,
Largest Commercial Agreement ,
History Becomes Effective ,
Kamada Over ,
First Four Years ,
Eight Year ,
Continued Growth Through ,
Includes Potential Expansion ,
Additional Territories Beyond ,
Conference Call ,
Live Webcast Today ,
Eastern Time ,
Safety Information ,
Medicines Agency ,
Exchange Act ,
Securities Litigation Reform Act ,
Annual Report ,
Sci Advisors ,
Markets ,